Cite

HARVARD Citation

    Mccabe, A. et al. (n.d.). An audit on the outcomes of patients with primary lung cancer treated with stereotactic ablative radiotherapy (SABR) at a single institute between 2013 and 2018. Lung cancer. pp. S76-. [Online]. 
  
Back to record